This is a pivotal moment for Quanta, as we start to bring SC+ to the United States to improve how patients receive dialysis care. We are privileged to work with such a distinguished group of nephrologists as members of our Medical Advisory Board. This ensures that we will have the guidance and insights needed to make a positive impact on dialysis experiences for both patients and healthcare providers.